Barry Du Bois has today shaved off his locks in a nod to his own journey with the blood cancer myeloma, for the Leukaemia Foundation’s iconic World’s Greatest Shave. It’s no secret that this much-loved and well-known Aussie, has been living with the incurable blood cancer since he was diagnosed in 2017.
Patients understand that clinical best practice care begins with an accurate and timely diagnosis.
Jennifer Marx shares insight into being diagnosed with myeloma at almost 27 years old - a condition far more prevalent in older people. Jennifer shares how she navigated the healthcare system, managed treatment and relationships, and her experience having two autologous transplants.
For the third time, selinexor (Xpovio®) will be considered by the Pharmaceutical Benefits Advisory Committee (PBAC) at its November 2022 meeting for the treatment of relapsed/refractory (R/R) myeloma.Â
During the 22 years Martin Boling has had myeloma, blood cancer of various types has affected four other members of his family too, not just him.Â
Meet the research team developing a myeloma treatment with maximum efficacy and minimal side effects
Northern Territory local Robert Smith had been living on dialysis for 12 years when he was diagnosed with myeloma. Robert discusses the importance that the support of his wife, Jo was in his journey. He takes us through his story — from diagnosis, to what it was like to travel to Adelaide for life-saving treatment and his recovery.
Andrew was the first person in Western Australia to have the life-changing therapy.
Ann Bruce shares the story of her diagnosis, in her own words.
Ciltacabtagene autoleucel (cilta-cel), is being appraised by the Medical Services Advisory Committee (MSAC) for listing on the Medicare Benefits Schedule.Â
